D-serine Augmentation of Neuroplasticity

Clinical trial NCT03711500 · COMPLETED

Trial details

NCT number: NCT03711500
Sponsor: New York State Psychiatric Institute
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Schizophrenia Schizo Affective Disorder

Start date: 2019-03-13
Primary completion: 2021-04-30
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.